Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
Authors:
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 61 (1) , 198-210.e1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Interventions for alleviating cancer-related dyspnea: A systematic review and meta-analysisActa Oncologica, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trialsBMJ, 2011
- Pharmacotherapy for acute heart failure syndromesAmerican Journal of Health-System Pharmacy, 2011
- Morphine Versus Midazolam as Upfront Therapy to Control Dyspnea Perception in Cancer Patients While Its Underlying Cause Is Sought or TreatedJournal of Pain and Symptom Management, 2010
- Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized SalineJournal of Pain and Symptom Management, 2008
- The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical TrialsJournal of Clinical Oncology, 2008
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Nebulized hydromorphone for dyspnea in hospice care of advanced cancerAmerican Journal of Hospice and Palliative Medicine®, 2000
- Effects of morphine on the dyspnea of terminal cancer patientsJournal of Pain and Symptom Management, 1990